Pharmacokinetics of Suvorexant in Participants With Hepatic Insufficiency (MK-4305-017)

Summary

This study will determine whether the plasma concentration-time profile and pharmacokinetics (PK) of suvorexant (MK-4305) in participants with moderate and mild hepatic insufficiency are similar to those observed in healthy participants.

Timeline

Start

2010-02-22

Primary completion

2010-04-14

Completion

2010-04-14

Drugs

Indications